Companies
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
EGA Report Criticises EU Patent System
June 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
A report published by the European Generic Medicines Association (EGA) has criticised the way in which the EU patent system can be abused by research-based pharmaceutical companies to delay market access for generic medicines. The paper, titled 'Patent Related Barriers to Market Entry for Generic Medicines in the European Union', assesses the methods used by companies and makes recommendations to overcome the associated